Telemonitoring for chronic obstructive pulmonary disease: a cost and cost-utility analysis of a randomised controlled trial

Andrew Stoddart; Marjon van der Pol; Hilary Pinnock; Janet Hanley; Lucy McCloughan; Allison Todd; Ashma Krishan; Brian McKinstry

doi:10.1177/1357633X14566574

Telemonitoring for chronic obstructive pulmonary disease: a cost and cost-utility analysis of a randomised controlled trial

Andrew Stoddart^*, Marjon van der Pol, Hilary Pinnock, Janet Hanley, Lucy McCloughan, Allison Todd, Ashma Krishan, Brian McKinstry

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract / Description of output

We compared the costs and cost-effectiveness of telemonitoring vs usual care for patients with chronic obstructive pulmonary disease (COPD). A total of 256 patients were randomised to either telemonitoring or usual care. In the telemonitoring arm, the touch-screen telemonitoring equipment transmitted data to clinical teams monitoring the patients. Total healthcare costs were estimated over a 12-month period from a National Health Service perspective and quality adjusted life year (QALYs) were estimated by the EQ-5D tool. Telemonitoring was not significantly more costly than usual care (mean difference per patient 2065.90 pound (P

Original language	English
Pages (from-to)	108-118
Number of pages	11
Journal	Journal of Telemedicine and Telecare
Volume	21
Issue number	2
Early online date	13 Jan 2015
DOIs	https://doi.org/10.1177/1357633X14566574
Publication status	Published - 1 Mar 2015

Keywords / Materials (for Non-textual outputs)

Aged
Cost-Benefit Analysis
Female
Health Care Costs
Humans
Male
Middle Aged
Pulmonary Disease, Chronic Obstructive
Quality of Life
Quality-Adjusted Life Years
State Medicine
Surveys and Questionnaires
Telemedicine
United Kingdom
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Access to Document

10.1177/1357633X14566574

Cite this

@article{53ce1268073d496c8526ec3f699a5964,

title = "Telemonitoring for chronic obstructive pulmonary disease: a cost and cost-utility analysis of a randomised controlled trial",

abstract = "We compared the costs and cost-effectiveness of telemonitoring vs usual care for patients with chronic obstructive pulmonary disease (COPD). A total of 256 patients were randomised to either telemonitoring or usual care. In the telemonitoring arm, the touch-screen telemonitoring equipment transmitted data to clinical teams monitoring the patients. Total healthcare costs were estimated over a 12-month period from a National Health Service perspective and quality adjusted life year (QALYs) were estimated by the EQ-5D tool. Telemonitoring was not significantly more costly than usual care (mean difference per patient 2065.90 pound (P",

keywords = "Aged, Cost-Benefit Analysis, Female, Health Care Costs, Humans, Male, Middle Aged, Pulmonary Disease, Chronic Obstructive, Quality of Life, Quality-Adjusted Life Years, State Medicine, Surveys and Questionnaires, Telemedicine, United Kingdom, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't",

author = "Andrew Stoddart and {van der Pol}, Marjon and Hilary Pinnock and Janet Hanley and Lucy McCloughan and Allison Todd and Ashma Krishan and Brian McKinstry",

note = "{\textcopyright} The Author(s) 2015 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.",

year = "2015",

month = mar,

day = "1",

doi = "10.1177/1357633X14566574",

language = "English",

volume = "21",

pages = "108--118",

journal = "Journal of Telemedicine and Telecare",

issn = "1357-633X",

publisher = "SAGE Publications",

number = "2",

}

TY - JOUR

T1 - Telemonitoring for chronic obstructive pulmonary disease

T2 - a cost and cost-utility analysis of a randomised controlled trial

AU - Stoddart, Andrew

AU - van der Pol, Marjon

AU - Pinnock, Hilary

AU - Hanley, Janet

AU - McCloughan, Lucy

AU - Todd, Allison

AU - Krishan, Ashma

AU - McKinstry, Brian

N1 - © The Author(s) 2015 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - We compared the costs and cost-effectiveness of telemonitoring vs usual care for patients with chronic obstructive pulmonary disease (COPD). A total of 256 patients were randomised to either telemonitoring or usual care. In the telemonitoring arm, the touch-screen telemonitoring equipment transmitted data to clinical teams monitoring the patients. Total healthcare costs were estimated over a 12-month period from a National Health Service perspective and quality adjusted life year (QALYs) were estimated by the EQ-5D tool. Telemonitoring was not significantly more costly than usual care (mean difference per patient 2065.90 pound (P

AB - We compared the costs and cost-effectiveness of telemonitoring vs usual care for patients with chronic obstructive pulmonary disease (COPD). A total of 256 patients were randomised to either telemonitoring or usual care. In the telemonitoring arm, the touch-screen telemonitoring equipment transmitted data to clinical teams monitoring the patients. Total healthcare costs were estimated over a 12-month period from a National Health Service perspective and quality adjusted life year (QALYs) were estimated by the EQ-5D tool. Telemonitoring was not significantly more costly than usual care (mean difference per patient 2065.90 pound (P

KW - Aged

KW - Cost-Benefit Analysis

KW - Female

KW - Health Care Costs

KW - Humans

KW - Male

KW - Middle Aged

KW - Pulmonary Disease, Chronic Obstructive

KW - Quality of Life

KW - Quality-Adjusted Life Years

KW - State Medicine

KW - Surveys and Questionnaires

KW - Telemedicine

KW - United Kingdom

KW - Journal Article

KW - Randomized Controlled Trial

KW - Research Support, Non-U.S. Gov't

U2 - 10.1177/1357633X14566574

DO - 10.1177/1357633X14566574

M3 - Article

C2 - 25586810

SN - 1357-633X

VL - 21

SP - 108

EP - 118

JO - Journal of Telemedicine and Telecare

JF - Journal of Telemedicine and Telecare

IS - 2

ER -

Telemonitoring for chronic obstructive pulmonary disease: a cost and cost-utility analysis of a randomised controlled trial

Abstract / Description of output

Keywords / Materials (for Non-textual outputs)

Access to Document

Fingerprint

Cite this